Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...

While many people are familiar with mammograms and smear tests, prostate screening is talked about far less. Ahead of Prostate Cancer Awareness Month in March, Mr Wissam Abou-Chedid, consultant ...

A urine-based biomarker panel detected prostate cancer in 91% of specimens with a diagnostic accuracy of 78.6% to 85.7%, according to a study published Sept. 2 in eBioMedicine. Led by a team from ...

Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...

It’s important to follow guidance on prostate-specific antigen screening that maximizes benefits and minimizes potential harms such as overdiagnosis and overtreatment.

Private companies are capitalizing on this quest for information. Grail’s Galleri blood test screens for more than 50 ...

Learn the key warning signs of prostate cancer that men often overlook. Early awareness can make all the difference.

Cancer is the No. 1 cause of line-of-duty deaths among firefighters, who are 9% more likely than the general population to be ...

While many people are familiar with mammograms and smear tests, prostate screening is talked about far less.To shed light on this important subject ahead of Prostate Cancer Awareness Month in March, ...